PHK
RDY icon

Point72 Hong Kong’s Dr. Reddy's Laboratories RDY Stock Holding History

Point72 Hong Kong’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,335
Closed -$74.2K – 753
2023
Q4 		$74.2K Buy
+5,335
New +$71.3K ﹤0.01% 500

Other funds holding RDY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's RDY Position: Q1 2024 in Review

Point72 Hong Kong sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 5,335 shares — an estimated $74.2K sold.

Point72 Hong Kong first reported a position in RDY in Q4 2023 and held it in 1 quarter. The position peaked at $74.2K in Q4 2023. 230 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • Point72 Hong Kong reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 5,335 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $74.2K.
  • Point72 Hong Kong first reported a position in Dr. Reddy's Laboratories in Q4 2023 and held it in 1 quarter.
  • Point72 Hong Kong's Dr. Reddy's Laboratories position peaked at $74.2K in Q4 2023.
  • 230 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.